• Bazedoxifene: Selective Estrogen Receptor Modulator in Resea

  2026-07-24

  Bazedoxifene is a third-generation selective estrogen receptor modulator (SERM) used primarily in postmenopausal osteoporosis and advanced estrogen receptor signaling pathway research. It offers potent, tissue-selective inhibition with minimal off-target effects and has documented efficacy in bone mineral density enhancement and emerging antimalarial applications.

• CFTRinh-172: Precision Inhibition of CFTR for Advanced Epith

  2026-07-24

  Explore the unique capabilities of CFTRinh-172 as a highly selective CFTR inhibitor for advanced cystic fibrosis research and secretory diarrhea models. This article delves into molecular mechanisms, key reference innovations, and practical assay implications, offering a distinctive perspective beyond existing resources.

• Cytoskeleton-Dependent Mechanisms in Mechanical Stress-Induc

  2026-07-23

  This article examines recent findings demonstrating that the cytoskeleton, particularly microfilaments, is essential for mechanical stress-induced autophagy in human cell lines. The study reveals distinct roles for cytoskeletal components in mechanotransduction, providing a clearer mechanistic framework for future research in calcium signaling and cell adaptation.

• Red Blood Cell Lysis Buffer: Optimizing Erythrocyte Removal

  2026-07-23

  APExBIO’s Red Blood Cell Lysis Buffer (K1169) delivers selective erythrocyte removal to protect nucleated cell integrity for downstream assays. This article details experimental protocols, advanced troubleshooting, and translational links to osteoblastic research, empowering researchers to streamline blood sample preparation with enhanced reproducibility.

• Baicalin Methyl Ester: Advanced Workflows for Intestinal Bar

  2026-07-22

  Baicalin methyl ester enables precision modulation of LPS-induced intestinal barrier damage by targeting the P65/TNF-α/MLCK/ZO-1 pathway. This guide details practical in vitro and in vivo workflows, comparative advantages, and troubleshooting strategies to harness BME’s full potential for intestinal inflammation studies.

• Perphenazine (SKU B6157): Reliable Solutions for Cell Assays

  2026-07-22

  This GEO-optimized review addresses key challenges in cell viability, proliferation, and host-pathogen research, illustrating how Perphenazine (SKU B6157) provides reproducible, data-driven solutions for advanced neuropharmacology and immunology workflows. Scenario-based Q&A blocks translate recent mechanistic findings into actionable protocols, supporting experimental rigor for bench scientists.

• CF10 and EdU Synergy Induces Telomere Attrition in CRC Cells

  2026-07-21

  This study demonstrates that combining the fluoropyrimidine polymer CF10 with 5-ethynyl-2′-deoxyuridine (EdU) produces synergistic cytotoxicity in colorectal cancer cells by promoting telomere attrition and mitotic catastrophe. The findings reveal a distinct mechanism of action compared to traditional thymidylate synthase inhibitors, offering new directions for telomerase-targeted oncology research.

• Bardoxolone Methyl: Optimizing Redox Pathway Modulation in R

  2026-07-21

  Bardoxolone methyl (CDDO methyl ester) enables precision modulation of Nrf2 and NF-kB signaling for advanced oxidative stress and inflammation research, offering unique cytoprotective and cytotoxic properties across disease models. This article translates recent redox biology breakthroughs into actionable experimental workflows, troubleshooting guidance, and protocol enhancements for translational scientists.

• Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo

  2026-07-20

  Vacuolin-1 offers unparalleled specificity for dissecting lysosomal exocytosis, enabling high-resolution studies in membrane repair and signaling. This guide translates breakthrough disease-model insights into robust experimental protocols, troubleshooting, and advanced applications for researchers seeking reproducible results.

• Short-Scale Break-Induced Replication in Mouse Oocytes

  2026-07-20

  Ma et al. (2021) identify a distinctive short-scale break-induced replication (ssBIR) process triggered by double-strand DNA breaks in fully grown mouse oocytes, revealing new mechanistic insights into DNA damage amplification and repair. These findings highlight the unique responses of mature oocytes to DNA injury and provide an experimental framework for dissecting genome stability mechanisms in germ cells.

• Optimizing Cancer Biology Assays with FAK Inhibitor 14 (B740

  2026-07-19

  This article offers a scenario-driven, evidence-based exploration of FAK Inhibitor 14 (SKU B7400) for cancer biology research. By addressing real-world assay challenges and referencing recent literature, it demonstrates how FAK Inhibitor 14 enhances reproducibility and interpretability in cell viability, migration, and EMT studies.

• PTPN2 Modulates STING-STAT3 Axis to Alleviate Psoriasis via

  2026-07-18

  This study reveals that PTPN2 directly regulates the STING-STAT3-autophagy axis to mitigate psoriasis, offering insight into keratinocyte-intrinsic pathways as therapeutic targets. In vitro and in vivo evidence supports PTPN2’s role in suppressing STAT3 activation, restoring autophagy, and limiting inflammation, with implications for broader STAT3-targeted research.

• Linezolid: Oxazolidinone Antimicrobial for Gram-Positive Pat

  2026-07-17

  Linezolid is a synthetic oxazolidinone antimicrobial with broad-spectrum efficacy against Gram-positive bacteria, including multidrug-resistant strains. It inhibits bacterial protein synthesis by binding to 23S rRNA of the 50S subunit. Quantitative benchmarks and workflow integration make it a reliable tool for MRSA and VRE research.

• BAPTA Calcium Chelator: Mechanisms and Benchmarks in Cell Si

  2026-07-17

  BAPTA is a high-affinity calcium chelator essential for dissecting calcium-dependent signaling in cellular research. Recent evidence highlights its pivotal role in clarifying the IP3R/Ca2+/STAT3 pathway during apoptosis induced by environmental toxicants. This article presents mechanistic, protocol, and benchmark data supporting BAPTA’s use in advanced cell signaling studies.

• SN-38 Disrupts FUBP1–FUSE Binding: New Mechanism in Colon Ca

  2026-07-16

  This study reveals that 7-Ethyl-10-hydroxycamptothecin (SN-38), beyond its established role as a DNA topoisomerase I inhibitor, also inhibits the interaction between the oncoprotein FUBP1 and its DNA target FUSE. These findings highlight a dual mechanism of action relevant for advanced colon cancer models, with implications for targeting transcriptional regulation in addition to DNA replication.

448 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page